ALK-Abelló A/S (AKBLF)
OTCMKTS · Delayed Price · Currency is USD
35.80
-0.30 (-0.83%)
At close: Jan 26, 2026
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of $7.49 billion as of February 12, 2026. Its market cap has increased by 55.36% in one year.
Market Cap
7.49B
Enterprise Value
7.45B
Revenue
954.84M
Ranking
n/a
PE Ratio
43.28
Stock Price
$35.80
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 1.10B to 7.49B, an increase of 581.77%. That is a compound annual growth rate of 10.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 7.49B | -6.01% |
| Dec 30, 2025 | 7.96B | 62.61% |
| Dec 30, 2024 | 4.90B | 47.54% |
| Dec 29, 2023 | 3.32B | 8.87% |
| Dec 30, 2022 | 3.05B | -46.82% |
| Dec 30, 2021 | 5.73B | 27.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |